Showing results (361-370 of 442) with videos related to
Sort By:
Pageof 45
Plos One|June 24, 2011
Diaphragm muscle weakness in an experimental porcine intensive care unit modelJulien Ochala, Guillaume Renaud, Monica Llano Diez, et al.Physiological Genomics|August 27, 2009
Gene expression and muscle fiber function in a porcine ICU modelVaruna C Banduseela, Julien Ochala, Yi-Wen Chen, et al.Cardiovascular Diabetology|April 25, 2024
Stroke incidence increases with diabetic retinopathy severity and macular edema in type 1 diabetesMarika I Eriksson, Kustaa Hietala, Paula Summanen, et al.Nature|August 31, 1999
Abnormal mast cells in mice deficient in a heparin-synthesizing enzymeE Forsberg, G Pejler, M Ringvall, et al.Journal of Thrombosis and Haemostasis : JTH|August 1, 2007
A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgeryB I Eriksson, A G G Turpie, M R Lassen, et al.The Journal of Bone and Joint Surgery. British Volume|May 2, 2009
Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacementB I Eriksson, A K Kakkar, A G G Turpie, et al.Physiological Genomics|October 20, 2011
Mechanisms underlying the sparing of masticatory versus limb muscle function in an experimental critical illness modelSudhakar Aare, Julien Ochala, Holly S Norman, et al.The Journal of Physiology|May 23, 2012
The human carotid body transcriptome with focus on oxygen sensing and inflammation--a comparative analysisSouren Mkrtchian, Jessica Kåhlin, Anette Ebberyd, et al.Clinical Pharmacokinetics|July 8, 2003
Pharmacokinetics of melagatran and the effect on ex vivo coagulation time in orthopaedic surgery patients receiving subcutaneous melagatran and oral ximelagatran: a population model analysisUlf G Eriksson, Jaap W Mandema, Mats O Karlsson, et al.Thrombosis and Haemostasis|February 8, 2003
Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacementBengt I Eriksson, Giancarlo Agnelli, Alexander T Cohen, et al.Pageof 45